Outcometrix is a consulting firm specializing in the design, implementation, analysis, and reporting of clinical outcome assessments (COA). We provide scientific and regulatory advice to the pharmaceutical industry related to the use of COAs in all phases of drug development. Outcometrix was founded to provide accessible, senior-level scientific consulting. The name “Outcometrix” is a stylized portmanteau originating from the words outcome (something that happens as a result of an activity or process) and metrics (a method of measuring something). The name represents not only what we do, but also the modern approach we take to solve problems.